HXA
DOCOSA-4,7,10,13,16,19-HEXAENOIC ACID
Find entries where: HXA
is present as a standalone ligand in 15 entries
Chemical Component Summary | |
---|---|
Name | DOCOSA-4,7,10,13,16,19-HEXAENOIC ACID |
Identifiers | (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid |
Formula | C22 H32 O2 |
Molecular Weight | 328.488 |
Type | NON-POLYMER |
Isomeric SMILES | CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)O |
InChI | InChI=1S/C22H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-21H2,1H3,(H,23,24)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18- |
InChIKey | MBMBGCFOFBJSGT-KUBAVDMBSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 56 |
Chiral Atom Count | 0 |
Bond Count | 55 |
Aromatic Bond Count | 0 |
Drug Info: DrugBank
DrugBank ID | DB03756 |
---|---|
Name | Doconexent |
Groups |
|
Description | A mixture of fish oil and primrose oil, doconexent is used as a high-docosahexaenoic acid (DHA) supplement. DHA is a 22 carbon chain with 6 cis double bonds with anti-inflammatory effects. It can be biosythesized from alpha-linolenic acid or commercially manufactured from microalgae. It is an omega-3 fatty acid and primary structural component of the human brain, cerebral cortex, skin, and retina thus plays an important role in their development and function. The amino-phospholipid DHA is found at a high concentration across several brain subcellular fractions, including nerve terminals, microsomes, synaptic vesicles, and synaptosomal plasma membranes [A19436]. |
Synonyms |
|
Brand Names |
|
Indication | Used as a high-docosahexaenoic acid (DHA) oral supplement. |
Categories |
|
CAS number | 6217-54-5 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Peroxisome proliferator-activated receptor alpha | MVDTESPLCPLSPLEAGDLESPLSEEFLQEMGNIQEISQSIGEDSSGSFG... | unknown | activator |
Peroxisome proliferator-activated receptor gamma | MGETLGDSPIDPESDSFTDTLSANISQEMTMVDTEMPFWPTNFGISSVDL... | unknown | activator |
Retinoic acid receptor RXR-alpha | MDTKHFLPLDFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSP... | unknown | activator |
Retinoic acid receptor RXR-beta | MSWAARPPFLPQRHAAGQCGPVGVRKEMHCGVASRWRRRRPWLDPAAAAA... | unknown | activator |
Retinoic acid receptor RXR-gamma | MYGNYSHFMKFPAGYGGSPGHTGSTSMSPSAALSTGKPMDSHPSYTDTPV... | unknown | activator |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 445580 |
ChEMBL | CHEMBL367149 |
ChEBI | CHEBI:28125 |